{"id":2823,"date":"2025-07-31T11:44:36","date_gmt":"2025-07-31T11:44:36","guid":{"rendered":"https:\/\/luminorecruit.com\/?p=2823"},"modified":"2025-07-31T13:24:58","modified_gmt":"2025-07-31T13:24:58","slug":"verschreibungen-von-medizinischem-cannabis-verdoppeln-sich-jahrlich-in-grosbritannien-cbpm-bericht","status":"publish","type":"post","link":"https:\/\/luminorecruit.com\/de\/medical-cannabis-prescriptions-doubling-annually-in-the-uk-cbpm-report\/","title":{"rendered":"130% Zunahme der Verschreibungen von medizinischem Cannabis im Vereinigten K\u00f6nigreich - ein CBPM-\u00dcberblick"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"2823\" class=\"elementor elementor-2823\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1f69a14 e-flex e-con-boxed e-con e-parent\" data-id=\"1f69a14\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4f88b72 elementor-widget elementor-widget-heading\" data-id=\"4f88b72\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">TL;DR - Executive Summary<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6ded794 elementor-widget elementor-widget-text-editor\" data-id=\"6ded794\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>In the UK, cannabis-based products for medicinal use (CBPMs) are classified a Class B drug under Schedule 2 and prescribed only by <a href=\"#who-can-prescribe-cbpms\">GMC-registered specialists<\/a>. Recreational use of cannabis remains illegal.<\/li><li><a href=\"#CBPM-Growth-2024\">Unlicensed CBPM prescriptions in the private sector are<\/a> <a href=\"#CBPM-Growth-2024\">quickly rising<\/a> &#8211; especially in the past 3 years. However, CBPM prescriptions by the NHS are negligible &#8211; only under 5 a month.\u00a0<\/li><li>CBPM prescriptions in the private sector have risen 130% in 2024 compared to 2023, according to a <a href=\"https:\/\/www.cqc.org.uk\/publications\/controlled-drugs\/2024\/issues\" target=\"_blank\" rel=\"noopener\" data-wplink-edit=\"true\">report by the Care Quality Commission (CQC)<\/a><\/li><li>The <a href=\"#CBPM-prescriptions-dwarf-mainstream-drugs\">percentage growth of prescriptions for CBPMs exceed those of mainstream drugs<\/a> such as Atorvastatin, Amlodipine, Omeprazole and Ramipril.<\/li><li>However, the CQC expresses its concerns around <a href=\"#CBPM-coordination-communication\">poor communication &amp; coordination<\/a> between providers, GPs and the patients themselves, the <a href=\"#CBPM-safety-and-legality\">questionable safety &amp; legality<\/a> of current prescriptions, the lack of documented evidence justifying a CBPM will fulfill an <a href=\"#CBPM-unmet-clinical-need\">unmet clinical need<\/a>, and the adherence to <a href=\"#CBPM-advertising\">ethical advertising<\/a> practices.<\/li><li>Growth for UK&#8217;s medical cannabis industry is promising &#8211; but this should not come at the cost of compliance to ensure safety &amp; quality of life for all patients.<\/li><li>Guidance on <a href=\"#CBPM-prescription-proof\">how to prove you have a CBPM prescription<\/a> is provided as well as a link to access a <a href=\"#CBPM-E-Learning-Package-NHS\">NHS&#8217;s CBPM e-learning package<\/a> (only for UK healthcare professionals).<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-43b8882 elementor-widget elementor-widget-spacer\" data-id=\"43b8882\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3c0d3e2 elementor-widget-divider--separator-type-pattern elementor-widget-divider--no-spacing elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"3c0d3e2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\" style=\"--divider-pattern-url: url(&quot;data:image\/svg+xml,%3Csvg xmlns=&#039;http:\/\/www.w3.org\/2000\/svg&#039; preserveAspectRatio=&#039;xMidYMid meet&#039; overflow=&#039;visible&#039; height=&#039;100%&#039; viewBox=&#039;0 0 126 26&#039; fill=&#039;black&#039; stroke=&#039;none&#039;%3E%3Cpath d=&#039;M3,10.2c2.6,0,2.6,2,2.6,3.2S4.4,16.5,3,16.5s-3-1.4-3-3.2S0.4,10.2,3,10.2z M18.8,10.2c1.7,0,3.2,1.4,3.2,3.2s-1.4,3.2-3.2,3.2c-1.7,0-3.2-1.4-3.2-3.2S17,10.2,18.8,10.2z M34.6,10.2c1.5,0,2.6,1.4,2.6,3.2s-0.5,3.2-1.9,3.2c-1.5,0-3.4-1.4-3.4-3.2S33.1,10.2,34.6,10.2z M50.5,10.2c1.7,0,3.2,1.4,3.2,3.2s-1.4,3.2-3.2,3.2c-1.7,0-3.3-0.9-3.3-2.6S48.7,10.2,50.5,10.2z M66.2,10.2c1.5,0,3.4,1.4,3.4,3.2s-1.9,3.2-3.4,3.2c-1.5,0-2.6-0.4-2.6-2.1S64.8,10.2,66.2,10.2z M82.2,10.2c1.7,0.8,2.6,1.4,2.6,3.2s-0.1,3.2-1.6,3.2c-1.5,0-3.7-1.4-3.7-3.2S80.5,9.4,82.2,10.2zM98.6,10.2c1.5,0,2.6,0.4,2.6,2.1s-1.2,4.2-2.6,4.2c-1.5,0-3.7-0.4-3.7-2.1S97.1,10.2,98.6,10.2z M113.4,10.2c1.2,0,2.2,0.9,2.2,3.2s-0.1,3.2-1.3,3.2s-3.1-1.4-3.1-3.2S112.2,10.2,113.4,10.2z&#039;\/%3E%3C\/svg%3E&quot;);\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f111eb9 elementor-widget elementor-widget-spacer\" data-id=\"f111eb9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-66289d4 elementor-widget elementor-widget-heading\" data-id=\"66289d4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h4 class=\"elementor-heading-title elementor-size-default\">Table of Contents<\/h4>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5e8ebe9 elementor-widget elementor-widget-text-editor\" data-id=\"5e8ebe9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><a href=\"#UK-Medicinal-cannabis-overview-2025\"><strong>2025 overview of Medicinal Cannabis in the UK<\/strong><\/a><ul><li><a href=\"#CBPM-vs-CBM\">How are CBMs different from CBPMs?<\/a><\/li><li><a href=\"#licensed-vs-unlicensed-CBPMs\">&#8216;Licensed&#8217; vs &#8216;Unlicensed&#8217; CBPMs<\/a><\/li><li><a href=\"#who-can-prescribe-cbpms\">Who can prescribe CBPMs<\/a><\/li><li><a href=\"#cannabis-schedule-1-uk\">Cannabis-based products remaining under Schedule 1<\/a><\/li><\/ul><\/li><li><strong><a href=\"#CBPM-Growth-2024\">Any Growth in CBPM Prescriptions Since 2018&#8217;s Legalisation?<\/a><\/strong><ul><li><a href=\"#CBPM-NHS\" rel=\"noopener\">Patients being turned away by the NHS\u00a0<\/a><\/li><li><a href=\"#CBPM-Private-Sector-Boom\">Private sector boom in CBPM prescriptions<\/a><\/li><li><a href=\"#CBPM-prescriptions-dwarf-mainstream-drugs\">CBPMs exceed percentage growth of mainstream drugs<\/a><\/li><li><a href=\"#what-is-CBPM-prescribed-for\">What are CBPMs most commonly prescribed for?<\/a><\/li><li><a href=\"#CBPM-2025-data\">Is more current data available?<\/a><\/li><\/ul><\/li><li><strong><a href=\"#CBPM-Concerns\">Concerns about CBPMs<\/a><\/strong><ul><li><a href=\"#CBPM-coordination-communication\">1. Lack of Communication &amp; Coordination<\/a><\/li><li><a href=\"#CBPM-safety-and-legality\">2. Questionable Safety and Legality of Current Prescriptions<\/a><\/li><li><a href=\"#CBPM-unmet-clinical-need\">3. Must be an &#8220;Unmet Clinical Need&#8221;<\/a><\/li><li><a href=\"#CBPM-advertising\">4. Ethical Advertising<\/a><\/li><\/ul><\/li><li><a href=\"#CBPM-E-Learning-Package-NHS\">Access the CBPM E-Learning Package<\/a><\/li><li><a href=\"#CBPM-criteria\">CBPM criteria under the Regulation 2(1) of the Misuse of Drugs Regulations 2001<\/a><\/li><li><a href=\"#CBPM-prescription-proof\">How to prove I have a CBPM prescription?<\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-62ed5de elementor-widget elementor-widget-spacer\" data-id=\"62ed5de\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-33880a9 elementor-widget elementor-widget-heading\" data-id=\"33880a9\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"UK-Medicinal-cannabis-overview-2025\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">A 2025 Overview of Medicinal Cannabis in the UK<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-19c5db9 elementor-widget elementor-widget-text-editor\" data-id=\"19c5db9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>In the UK, cannabis is only permitted for medicinal means &#8211; while still remaining illegal for recreational use.<\/p><p>In 2018, several reviews were conducted by the British government into cannabis and cannabis-related products resulting in evidence that supported its medicinal benefit for certain conditions.<\/p><p>As a result, the government announced its intentions to allow providers to prescribe <a href=\"https:\/\/www.england.nhs.uk\/long-read\/cannabis-based-products-for-medicinal-use-cbpms\/\" target=\"_blank\" rel=\"noopener\">cannabis-based products for medicinal use (CBPMs)<\/a> with the first move being to<strong>\u00a0reclassify it from Schedule 1 to Schedule 2<\/strong> of the Misuse of Drugs Regulations 2001.<\/p><p>It is also important to note &#8211; as they may be easily confused &#8211; that CBPMs are an entirely distinct category from <strong>&#8216;cannabis-based medicines&#8217; (CBMs)<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-36a6267 elementor-widget elementor-widget-image\" data-id=\"36a6267\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-CBPM-vs-CBM-1024x768.webp\" class=\"attachment-large size-large wp-image-2847\" alt=\"A chart showing how medical cannabis in the UK is divided into 2 main categories: CBPM &amp; CBM\" srcset=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-CBPM-vs-CBM-1024x768.webp 1024w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-CBPM-vs-CBM-300x225.webp 300w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-CBPM-vs-CBM-768x576.webp 768w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-CBPM-vs-CBM.webp 1152w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-06c8842 elementor-widget elementor-widget-spacer\" data-id=\"06c8842\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c64871b elementor-widget elementor-widget-heading\" data-id=\"c64871b\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-vs-CBM\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">How are CBMs different from CBPMs?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c224b56 elementor-widget elementor-widget-text-editor\" data-id=\"c224b56\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Distinct from CBPMs, <em>&#8216;<strong>Cannabis-based medicines&#8217; (CBMs) <\/strong><\/em>are products that:<\/p><ul><li>are <strong>categorized and scheduled separately<\/strong> under the Misuse of Drugs Regulations<\/li><li>have <strong>received marketing authorization<\/strong> from the medicines regulator (either the MHRA or the EMA)<\/li><li>are <strong>licensed<\/strong> pharmaceutical products<\/li><li>can be <strong>prescribed by any General Practitioner (GP) <\/strong>&#8211; however, the lack of NHS authorisations and education hinders any growth in CBM prescriptions.<\/li><\/ul><p>Currently, there exists only 3 CBMs in the UK, namely: <a href=\"https:\/\/www.hweclinicalguidance.nhs.uk\/all-clinical-areas-documents\/download?cid=3889&amp;checksum=86098ef82c97fa789a47a8d2e8800794\" target=\"_blank\" rel=\"noopener\"><strong>Epidyolex, Nabilone, and Sativex<\/strong><\/a>. However, despite their legality &amp; availability, the <a href=\"https:\/\/cannabishealthnews.co.uk\/2024\/11\/06\/nhs-accused-of-failing-patients-as-families-make-fresh-plea-for-access\/\" target=\"_blank\" rel=\"noopener\">NHS strongly advises doctors not to freely prescribe them.<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-155bf82 elementor-widget elementor-widget-spacer\" data-id=\"155bf82\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6b2ae7c elementor-widget elementor-widget-heading\" data-id=\"6b2ae7c\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"licensed-vs-unlicensed-CBPMs\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">'Licensed' vs  'Unlicensed CBPMs'<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4b821b9 elementor-widget elementor-widget-text-editor\" data-id=\"4b821b9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em><strong>&#8216;Licensed CBPMs&#8217;<\/strong> <\/em>pertains to products that have <strong>received marketing authorisation<\/strong> from the medicines regulator (either the MHRA or the EMA), yet still meet the criteria of a CBPM under Regulation 2(1) of the MDR. <strong>As of 2025, the UK has no registered licensed CBPM.\u00a0<\/strong>It is generally understood that a licensed CBPM &#8211; passing rigorous clinical trial and receiving marketing authorisation &#8211; will <strong>most likely be classified as a CBM.<\/strong><\/p><p><em><strong>&#8216;Unlicensed CBPMs&#8217;<\/strong>, <\/em>on the other hand,\u00a0refers to products that meet the definition of a CBPM, but <strong>have not been evaluated for safety, quality or efficacy<\/strong> by regulatory bodies, such as the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA).<\/p><p>The <a href=\"https:\/\/www.gov.uk\/government\/publications\/supply-unlicensed-medicinal-products-specials\/supply-unlicensed-medicinal-products-specials\" target=\"_blank\" rel=\"noopener\">MHA offers guidance<\/a> on manufacturing, importing, distributing or supplying unlicensed CBPMs.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6eb3a1a elementor-widget elementor-widget-spacer\" data-id=\"6eb3a1a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-978ca9a elementor-widget elementor-widget-heading\" data-id=\"978ca9a\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"who-can-prescribe-cbpms\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Who can prescribe CBPMs?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b9533a2 elementor-widget elementor-widget-text-editor\" data-id=\"b9533a2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>According to the <a href=\"https:\/\/www.gmc-uk.org\/professional-standards\/learning-materials\/information-for-doctors-on-cannabis-based-products-for-medicinal-use\" target=\"_blank\" rel=\"noopener\">General Medical Council<\/a>, CBPM prescriptions can only be made:<\/p><ul><li>By <strong>doctors on the specialist register of the General Medical Council<\/strong><\/li><li>If it lies within the <strong>specialist doctor&#8217;s own area of practice and training\/limits of competence<\/strong><\/li><li>If the decision has been <strong>agreed upon by a multidisciplinary team<\/strong><\/li><li>When there is<strong> no other suitably licensed medicine available<\/strong> that will meet the patient\u2019s need.<\/li><\/ul><p>If you are a healthcare professional wanting to learn more, the National Health Service (NHS) England have developed an <a href=\"#CBPM-E-Learning-Package-NHS\">e-learning package<\/a> in 2018 in collaboration with the Health Education England and the University of Birmingham.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6ec1bdf elementor-widget elementor-widget-spacer\" data-id=\"6ec1bdf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-27022ee elementor-widget elementor-widget-heading\" data-id=\"27022ee\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"cannabis-schedule-1-uk\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Cannabis-based products remaining under Schedule 1<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6faa18b elementor-widget elementor-widget-text-editor\" data-id=\"6faa18b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Any cannabis-based products not meeting the <a href=\"#CBPM-criteria\">Misuse of Drugs Regulations 2001&#8217;s criteria<\/a> (other than cannabis-based medicines that have received marketing authorisation and have been separately scheduled) <strong>remain classified under Schedule 1, meaning it is unlawful to possess, supply, offer to supply, produce, import or export this drug except under a Home Office licence.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1cea9dd elementor-widget elementor-widget-spacer\" data-id=\"1cea9dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-59dd0c8 elementor-widget elementor-widget-heading\" data-id=\"59dd0c8\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-Growth-2024\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Any Growth in CBPM Prescriptions Since 2018's Legalisation?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-92737d5 elementor-widget elementor-widget-spacer\" data-id=\"92737d5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2c08a5f elementor-widget elementor-widget-heading\" data-id=\"2c08a5f\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-NHS\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Patients being turned away by the NHS<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ddcf28e elementor-widget elementor-widget-text-editor\" data-id=\"ddcf28e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>In the public sector, despite the 2018 law change, it has proven difficult to acquire medical cannabis from the NHS &#8211; especially for CBPMs.<\/p><p>When looking at CBMs (i.e., Epidyolex, Nabilone &amp; Sativex), a <a href=\"https:\/\/questions-statements.parliament.uk\/written-questions\/detail\/2024-12-04\/17970\" target=\"_blank\" rel=\"noopener\">statement by the UK&#8217;s Department of Health &amp; Social Care<\/a> reveals a steady increase in the number of NHS prescriptions for licensed cannabis-based medicines since 2018, with a 16% dip in 2024 (as seen in the diagram below).<\/p><p>However, these numbers are relatively low considering how in 2023 &#8211; the year with a noticeable spike &#8211; there were only 1,104 patients prescribed CBMs, an increase of merely 127 patients compared to 2021.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0449685 elementor-widget elementor-widget-image\" data-id=\"0449685\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"546\" src=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Number-of-licensed-CBM-prescriptions-from-the-NHS-1024x546.webp\" class=\"attachment-large size-large wp-image-2839\" alt=\"A graph showing the rising trend in CBM (cannabis-based medicine) prescriptions made by the NHS in the UK, from 2018 to 2024\" srcset=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Number-of-licensed-CBM-prescriptions-from-the-NHS-1024x546.webp 1024w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Number-of-licensed-CBM-prescriptions-from-the-NHS-300x160.webp 300w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Number-of-licensed-CBM-prescriptions-from-the-NHS-768x410.webp 768w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Number-of-licensed-CBM-prescriptions-from-the-NHS.webp 1500w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c72b763 elementor-widget elementor-widget-text-editor\" data-id=\"c72b763\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>When looking specifically at CBPMs, on the other hand, the number of NHS prescriptions for cannabis-based products for medicinal use were virtually negligible &#8211; <a href=\"https:\/\/www.bbc.com\/news\/health-66784170\" target=\"_blank\" rel=\"noopener\">often fewer than 5 per month<\/a> &#8211; as <a href=\"https:\/\/questions-statements.parliament.uk\/written-questions\/detail\/2023-01-06\/117459\" target=\"_blank\" rel=\"noopener\">revealed by former Health Minister, Will Quince in 2023.<\/a><\/p><p>These prescriptions went out to just a handful of <strong>children with<\/strong> <strong data-start=\"35\" data-end=\"99\">extremely rare, treatment-resistant epilepsies<\/strong> not controllable by standard therapies, such as a <a href=\"https:\/\/www.bbc.com\/news\/uk-england-somerset-67171305\" target=\"_blank\" rel=\"noopener\">four-year old girl with Aicardi syndrome<\/a>, a rare genetic neurological disorder.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-18dc703 elementor-widget elementor-widget-spacer\" data-id=\"18dc703\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-dca9581 elementor-widget elementor-widget-testimonial\" data-id=\"dca9581\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"testimonial.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-testimonial-wrapper\">\n\t\t\t\t\t\t\t<div class=\"elementor-testimonial-content\">\"The NHS Business Services Authority (NHSBSA) is unable to release information on prescribing of NHS Unlicensed Cannabis but can confirm that it is less than 5 prescriptions per month.\"<\/div>\n\t\t\t\n\t\t\t\t\t\t<div class=\"elementor-testimonial-meta\">\n\t\t\t\t<div class=\"elementor-testimonial-meta-inner\">\n\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-testimonial-details\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-testimonial-name\">Will Quince<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-testimonial-job\">Former Minister of State for Health in the UK<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-63192d3 elementor-widget elementor-widget-spacer\" data-id=\"63192d3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ae74ff5 elementor-widget elementor-widget-text-editor\" data-id=\"ae74ff5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The reasons?<\/p><ul><li>Most doctors <strong>lacked knowledge<\/strong> of medical cannabis, and\/or still saw the <strong>stigma<\/strong> associated with it.<\/li><li>Some specialists who are aware of it argue that there is <strong>not enough evidence regarding the drug&#8217;s safety and effectiveness<\/strong>\u00a0<b>(i.e., lack of randomized controlled trial (RCT) data) <\/b>to justify its prescription.<\/li><li>The specialists who do want to prescribe unlicensed cannabis-based products <strong>almost always get turned down for funding<\/strong> by the NHS.<\/li><li>NHS trusts <strong>often refer patients to private clinics.<\/strong><\/li><\/ul><p>Naturally, many patients, believing CBPMs could be freely prescribed by specialist doctors, felt misled. And as a result, they had to either forego, or pay privately.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bf31666 elementor-widget elementor-widget-spacer\" data-id=\"bf31666\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d01d102 elementor-widget elementor-widget-heading\" data-id=\"d01d102\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-Private-Sector-Boom\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">The Resulting Boom in Private Sector CBPM prescriptions<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b199e55 elementor-widget elementor-widget-text-editor\" data-id=\"b199e55\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Due to the difficulty in obtaining CBPMs from the NHS, many patients have instead opted for sourcing via the private sector. According to a recently released <a href=\"https:\/\/www.cqc.org.uk\/publications\/controlled-drugs\/2024\/issues\" target=\"_blank\" rel=\"noopener\">report of 2024 by the Care Quality Commission (CQC)<\/a>:<\/p><ul><li><strong>35 independent clinics<\/strong> were prescribing unlicensed CBPMs.<\/li><li>Almost all prescriptions for CBPMs remain <strong>within the private sector<\/strong>.<\/li><li>Comparing 2023 to 2024, the number of <strong>prescribed items jumped by<\/strong> <strong data-start=\"770\" data-end=\"778\">130%<\/strong> &#8211; from 150,527 (April &#8217;22 to March &#8217;23) to 346,600 (April &#8217;23 to March &#8217;24)<\/li><li>A <strong>clear upward trend<\/strong> in number of prescriptions, especially in the last 3 years.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7edfc30 elementor-widget elementor-widget-image\" data-id=\"7edfc30\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"546\" src=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-1024x546.webp\" class=\"attachment-large size-large wp-image-2825\" alt=\"Care Quality Commission (CQC) UK 2024 graphs showing the growth in CBPM prescriptions\" srcset=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-1024x546.webp 1024w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-300x160.webp 300w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-768x410.webp 768w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report.webp 1500w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-22373de elementor-widget elementor-widget-spacer\" data-id=\"22373de\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-21aea9c elementor-widget elementor-widget-heading\" data-id=\"21aea9c\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-prescriptions-dwarf-mainstream-drugs\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">CBPMs exceed percentage growth of mainstream drugs<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9596fc7 elementor-widget elementor-widget-text-editor\" data-id=\"9596fc7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>As seen in the table below comparing the annual number of prescription of CBPMs against the most prescribed drugs in the UK, from 2020 to 2024:<\/p><ul><li data-start=\"1863\" data-end=\"1904\"><p data-start=\"1865\" data-end=\"1904\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong>CBPM prescriptions, driven by the private sector, are indeed growing at a faster percentage rate<\/strong> (doubling annually or around 80\u202f% CAGR across 2021\u20132023), dwarfing percentage growth of mainstream drugs such as Atorvastatin, Amlodipine, Omeprazole, and Ramipril.<\/span><\/p><\/li><li data-start=\"1905\" data-end=\"1946\"><p data-start=\"1907\" data-end=\"1946\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong>But in absolute volume, CBPM prescriptions remain minuscule <\/strong>compared to the millions of prescriptions for statins, PPIs, and antihypertensives.<\/span><\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-47fa635 elementor-widget elementor-widget-image\" data-id=\"47fa635\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"546\" src=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Growth-in-prescriptions-for-Drugs-in-England-2024-1024x546.webp\" class=\"attachment-large size-large wp-image-2840\" alt=\"Table showing the annual number of prescriptions of England&#039;s most prescribed drugs compared to that for CBPMs (2020-2024), according to the NHS\" srcset=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Growth-in-prescriptions-for-Drugs-in-England-2024-1024x546.webp 1024w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Growth-in-prescriptions-for-Drugs-in-England-2024-300x160.webp 300w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Growth-in-prescriptions-for-Drugs-in-England-2024-768x410.webp 768w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-Growth-in-prescriptions-for-Drugs-in-England-2024.webp 1500w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0cb6ff8 elementor-widget elementor-widget-spacer\" data-id=\"0cb6ff8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b92de61 elementor-widget elementor-widget-heading\" data-id=\"b92de61\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"what-is-CBPM-prescribed-for\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">What are CBPMs most commonly prescribed for?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8a7772a elementor-widget elementor-widget-text-editor\" data-id=\"8a7772a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>According to a <a href=\"https:\/\/pharmaceutical-journal.com\/article\/feature\/demystifying-medical-cannabis-five-years-on-from-legalisation\" target=\"_blank\" rel=\"noopener\">2023 article by The Pharmaceutical Journal referencing a Project Twenty21 study<\/a>, the most common conditions CBPMs are prescribed for in the private sector are for chronic pain (e.g., back and\/or neck pain, arthritis) and psychiatric conditions (e.g., PTSD, ADHD)<\/p><p>These findings align with Lumino&#8217;s data based on the number of placements we&#8217;ve made for psychologists and neurologists in the UK over the past 4 years.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f677986 elementor-widget elementor-widget-image\" data-id=\"f677986\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"546\" src=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-reasons-for-prescribing-CBPM-1024x546.webp\" class=\"attachment-large size-large wp-image-2831\" alt=\"The most common conditions CBPM is being prescribed for with chronic pain conditions at 49%, psychiatric conditions at 42%, neurological conditions at 6% and others at 3%\" srcset=\"https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-reasons-for-prescribing-CBPM-1024x546.webp 1024w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-reasons-for-prescribing-CBPM-300x160.webp 300w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-reasons-for-prescribing-CBPM-768x410.webp 768w, https:\/\/luminorecruit.com\/wp-content\/uploads\/2025\/07\/7.30.25-UK-CBPM-2024-report-reasons-for-prescribing-CBPM.webp 1500w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d4d0cd0 elementor-widget elementor-widget-spacer\" data-id=\"d4d0cd0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ad5cd27 elementor-widget elementor-widget-heading\" data-id=\"ad5cd27\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-2025-data\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Is more current data available?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ed1a4ae elementor-widget elementor-widget-text-editor\" data-id=\"ed1a4ae\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>No. At the moment, these are the most current figures available.<\/p><p>CBPMs are not included in the <a href=\"https:\/\/www.nhsbsa.nhs.uk\/pharmacies-gp-practices-and-appliance-contractors\/dictionary-medicines-and-devices-dmd\" target=\"_blank\" rel=\"noopener\">Dictionary of medicines and devices (dm+d)<\/a> &#8211; as such, prescriptions aren&#8217;t compatible with the <a href=\"https:\/\/digital.nhs.uk\/services\/electronic-prescription-service\" target=\"_blank\" rel=\"noopener\">NHS&#8217;s Electronic Prescription Service (EPS)<\/a> and must be processed manually; hence, the time lag in the availability of prescription data.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-82dafff elementor-widget elementor-widget-spacer\" data-id=\"82dafff\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6a25e69 elementor-widget elementor-widget-heading\" data-id=\"6a25e69\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-Concerns\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">The Care Quality Commission's (CQC) concerns regarding CBPMs<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c541afb elementor-widget elementor-widget-text-editor\" data-id=\"c541afb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Despite the evident growth in CBPM prescriptions, there remain several persistent issues that can lead to the potential harm of patients, <a href=\"https:\/\/www.cqc.org.uk\/publications\/controlled-drugs\/2024\/issues\" target=\"_blank\" rel=\"noopener\">according to a CQC report<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f31246f elementor-widget elementor-widget-spacer\" data-id=\"f31246f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9bc983f elementor-widget elementor-widget-heading\" data-id=\"9bc983f\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-coordination-communication\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">1. Lack of Communication &amp; Coordination<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0949fdc elementor-widget elementor-widget-text-editor\" data-id=\"0949fdc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Some providers have <strong>failed to share treatment plans with other healthcare professionals<\/strong>, including patients&#8217; GPs. This lack of coordination can put patients at risk, especially when CBPMs are involved in complex care plans that require input from multiple specialists.<\/p><p>Secondly, clinics often fail to <strong>inform patients on how to prove they are in legal possession of a CBPM<\/strong>. As such, clinics should offer patients clear guidance during the CBPM prescription process. The NHS has published information on this &#8211; available in the <a href=\"#CBPM-prescription-proof\">footnotes of this blog article<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a00aa67 elementor-widget elementor-widget-spacer\" data-id=\"a00aa67\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-37a17c2 elementor-widget elementor-widget-heading\" data-id=\"37a17c2\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-safety-and-legality\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">2. Questionable Safety and Legality of Current Prescriptions<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-373cd1a elementor-widget elementor-widget-text-editor\" data-id=\"373cd1a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Most non-medical prescribing is done by pharmacists, so the first concern here is if all pharmacy prescribers do indeed <strong>work within their scope of practice<\/strong> (as highlighted in <a href=\"https:\/\/assets.pharmacyregulation.org\/files\/2024-01\/in-practice-guidance-for-pharmacist-prescribers-february-2020.pdf\" target=\"_blank\" rel=\"noopener\">this guide by the General Pharmaceutical Council<\/a>).<\/p><p>Secondly, by law, <strong>medical specialists should have oversight on patients&#8217; care &#8211; including prescriptions<\/strong>, so any services that prescribe CBPMs must certify for themselves that these medical specialists are exercising due diligence in the practice of this oversight.<\/p><p>Thirdly, it is essential that a <strong>peer review be conducted before prescriptions are made<\/strong>. This requires <strong>having a multi-disciplinary team comprising the relevant specialists to approve prescriptions<\/strong> &#8211; particularly for complex cases. Unfortunately, some clinics and small providers still fall short in these areas, and lack the appropriate specialisms in their team to make well-rounded decisions. Furthermore, such incidents are not always being reported as required.<\/p><p>As such, the CQC urges all providers to <strong>advise the relevant NHS England CDAO of any incident or concern that occurs<\/strong>, through the\u00a0<a href=\"http:\/\/www.cdreporting.co.uk\/\">Controlled drug reporting tool<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-650419f elementor-widget elementor-widget-spacer\" data-id=\"650419f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ab5719c elementor-widget elementor-widget-heading\" data-id=\"ab5719c\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-unmet-clinical-need\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">3. Must be an \"Unmet Clinical Need\"<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-803b52f elementor-widget elementor-widget-text-editor\" data-id=\"803b52f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>CBPMs should strictly be prescribed when there\u2019s a <strong>verifiable unmet clinical need<\/strong>.<\/p><p>According to the <a href=\"https:\/\/www.cqc.org.uk\/publications\/controlled-drugs\/2024\/issues\" target=\"_blank\" rel=\"noopener\">CQC<\/a>, CBPM prescriptions are made for a wide variety of medical conditions &#8211; some of these having arguably little evidence to justify CBPM use.<\/p><p>Some clinics suggest patients need to have tried two prior treatments, but this threshold isn&#8217;t always enough. Additionally, <strong>clear documentation is critical<\/strong> before prescribing and during the prescription (i.e., recorded in clinical notes).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-32ba58a elementor-widget elementor-widget-spacer\" data-id=\"32ba58a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4866986 elementor-widget elementor-widget-heading\" data-id=\"4866986\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-advertising\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">4. Ethical Advertising<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-16946f3 elementor-widget elementor-widget-text-editor\" data-id=\"16946f3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"1911\" data-end=\"2134\">CBPMs are unlicensed and prescription-only, which means they <strong>cannot be promoted like over-the-counter products<\/strong>. Furthermore, providers <strong>must follow <a href=\"https:\/\/www.gov.uk\/guidance\/advertise-your-medicines\" target=\"_blank\" rel=\"noopener\">MHRA advertising rules<\/a><\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-918756d elementor-widget elementor-widget-spacer\" data-id=\"918756d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e676181 elementor-widget-divider--separator-type-pattern elementor-widget-divider--no-spacing elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"e676181\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\" style=\"--divider-pattern-url: url(&quot;data:image\/svg+xml,%3Csvg xmlns=&#039;http:\/\/www.w3.org\/2000\/svg&#039; preserveAspectRatio=&#039;xMidYMid meet&#039; overflow=&#039;visible&#039; height=&#039;100%&#039; viewBox=&#039;0 0 126 26&#039; fill=&#039;black&#039; stroke=&#039;none&#039;%3E%3Cpath d=&#039;M3,10.2c2.6,0,2.6,2,2.6,3.2S4.4,16.5,3,16.5s-3-1.4-3-3.2S0.4,10.2,3,10.2z M18.8,10.2c1.7,0,3.2,1.4,3.2,3.2s-1.4,3.2-3.2,3.2c-1.7,0-3.2-1.4-3.2-3.2S17,10.2,18.8,10.2z M34.6,10.2c1.5,0,2.6,1.4,2.6,3.2s-0.5,3.2-1.9,3.2c-1.5,0-3.4-1.4-3.4-3.2S33.1,10.2,34.6,10.2z M50.5,10.2c1.7,0,3.2,1.4,3.2,3.2s-1.4,3.2-3.2,3.2c-1.7,0-3.3-0.9-3.3-2.6S48.7,10.2,50.5,10.2z M66.2,10.2c1.5,0,3.4,1.4,3.4,3.2s-1.9,3.2-3.4,3.2c-1.5,0-2.6-0.4-2.6-2.1S64.8,10.2,66.2,10.2z M82.2,10.2c1.7,0.8,2.6,1.4,2.6,3.2s-0.1,3.2-1.6,3.2c-1.5,0-3.7-1.4-3.7-3.2S80.5,9.4,82.2,10.2zM98.6,10.2c1.5,0,2.6,0.4,2.6,2.1s-1.2,4.2-2.6,4.2c-1.5,0-3.7-0.4-3.7-2.1S97.1,10.2,98.6,10.2z M113.4,10.2c1.2,0,2.2,0.9,2.2,3.2s-0.1,3.2-1.3,3.2s-3.1-1.4-3.1-3.2S112.2,10.2,113.4,10.2z&#039;\/%3E%3C\/svg%3E&quot;);\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-79a9075 elementor-widget elementor-widget-spacer\" data-id=\"79a9075\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0b51dba elementor-widget elementor-widget-heading\" data-id=\"0b51dba\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-E-Learning-Package-NHS\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Access the CBPM E-Learning Package<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-418ffda elementor-widget elementor-widget-text-editor\" data-id=\"418ffda\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>In 2018, NHS England, Health Education England, and the University of Birmingham created an <strong>e-learning package on medicinal cannabis, covering its pharmacology, legislation, therapeutic uses, and supporting evidence<\/strong>, accessible to all healthcare professionals.<\/p><p>You can access it via this link: <strong><a href=\"https:\/\/www.e-lfh.org.uk\/programmes\/cannabis-based-products-for-medicinal-use\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.e-lfh.org.uk\/programmes\/cannabis-based-products-for-medicinal-use\/<\/a><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a81126b elementor-widget elementor-widget-spacer\" data-id=\"a81126b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-04245b5 elementor-widget elementor-widget-heading\" data-id=\"04245b5\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-criteria\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">CBPM criteria under the Regulation 2(1) of the Misuse of Drugs Regulations 2001<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1ec6d1b elementor-widget elementor-widget-text-editor\" data-id=\"1ec6d1b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><em>Below is an excerpt from <a href=\"https:\/\/gowlingwlg.com\/en\/insights-resources\/articles\/2023\/prescribers-of-cannabis-based-medicinal-products\" target=\"_blank\" rel=\"noopener\">Gowling WLG&#8217;s summary<\/a> of the <a href=\"https:\/\/www.england.nhs.uk\/long-read\/cannabis-based-products-for-medicinal-use-cbpms\/\" target=\"_blank\" rel=\"noopener\">NHS&#8217;s guidance &amp; advice on CBPMs.<\/a><\/em><br \/><br \/>A cannabis-based product for medicinal use in humans (CBPM) is defined in Regulation 2(1) of the Misuse of Drugs Regulations 2001 (the 2001 Regulations). In summary, a CBPM must meet the following criteria:<\/p><ul><li><p>It must <strong>contain cannabis, cannabis resin, cannabinol, or a cannabinol derivative<\/strong>;<\/p><\/li><li><p>It must be <strong>produced for medicinal use in humans<\/strong>; and<\/p><\/li><li><p>It must either <strong>be a medicinal product (in regulatory terms) or a component of a medicinal product.<\/strong><\/p><\/li><\/ul><p>From 1 November 2018, the introduction of Regulation 16A into the 2001 Regulations provided that CBPMs are exempt from certain restrictions that would otherwise apply to controlled drugs under the Misuse of Drugs Act.<\/p><p>Regulation 16A does not represent a general relaxation of controls on CBPMs in England. Rather, it permits specific exemptions to the prohibitions in the Act, allowing the ordering or supply of a CBPM for administration in the following three situations:<\/p><ol><li><p>The CBPM <strong>holds a marketing authorisation<\/strong> (i.e. it is a licensed medicine). For example, NHS England identifies cannabidiol oral solution (Epidyolex\u00ae) as a licensed CBPM, having undergone randomised controlled trials for epilepsy syndromes such as Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex;<\/p><\/li><li><p>The CBPM is <strong>used for the purposes of a clinical trial<\/strong> (i.e. as an \u2018investigational\u2019 medicinal product). NHS England notes that such products are subject to assessment by the Medicines and Healthcare Products Regulatory Agency (MHRA) in relation to safety, quality, and efficacy\u2014unlike unlicensed medicines; or<\/p><\/li><li><p>The CBPM is <strong>administered under the prescription or direction of a \u2018specialist medical practitioner\u2019<\/strong>.<\/p><\/li><\/ol><p>The third scenario is broader in scope, as it permits the supply of any CBPM on the prescription or direction of a specialist medical practitioner. NHS England notes that \u201cthere is no restriction in law for which indications CBPMs may be prescribed,\u201d and that \u201cwhen prescribing CBPMs, it is a clinical decision to determine the most appropriate treatment for a patient.\u201d<\/p><p>Nonetheless, NHS England makes clear that the decision to prescribe a CBPM should not be taken lightly.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-53b388c elementor-widget elementor-widget-spacer\" data-id=\"53b388c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7cb0967 elementor-widget elementor-widget-heading\" data-id=\"7cb0967\" data-element_type=\"widget\" data-e-type=\"widget\" id=\"CBPM-prescription-proof\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">How to prove I have a CBPM prescription?<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e7b6332 elementor-widget elementor-widget-text-editor\" data-id=\"e7b6332\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-block-key=\"siav\"><em>The information below was taken from the guidance provided by the NHS (original article <a href=\"https:\/\/www.nhs.uk\/medicines\/medical-cannabis\/\" target=\"_blank\" rel=\"noopener\">here<\/a>):<\/em><\/p><p><strong>Keep your medicine in its original packaging<\/strong>, as the dispensing label contains important information about the medicine and the person it\u2019s prescribed for.<\/p><p data-block-key=\"hdgc\">The dispensing label is the label the pharmacist puts on the medicine packet when they give you your prescription medicine.<\/p><p data-block-key=\"8mqo3\">You should also <strong>keep a copy of your prescription, and a letter (if you have one) from the doctor who prescribed the medicine.<\/strong> The letter should include your personal details (including name and address), as well as the prescribing doctor\u2019s name and contact details.<\/p><p data-block-key=\"qod9\">You <strong>may need to show ID<\/strong> that matches the details on the dispensing label and the prescription, or the doctor\u2019s letter, if you have one.<\/p><p data-block-key=\"a9c0i\">Acceptable forms of ID include:<\/p><ul><li data-block-key=\"c8j4c\">valid passport<\/li><li data-block-key=\"bjt4g\">photo driving licence<\/li><li data-block-key=\"7epo2\">proof of age card, such as a PASS card from the national Proof of Age Standards Scheme<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-55e7163 e-flex e-con-boxed e-con e-parent\" data-id=\"55e7163\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>TL;DR - Zusammenfassung Im Vereinigten K\u00f6nigreich sind Produkte auf Cannabisbasis f\u00fcr den medizinischen Gebrauch (CBPMs) nach Schedule 2 als Arzneimittel der Klasse B eingestuft und d\u00fcrfen nur von GMC-registrierten Spezialisten verschrieben werden. Freizeitkonsum...<\/p>","protected":false},"author":2,"featured_media":2869,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":{"0":"post-2823","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-european-cannabis-industry"},"views":67,"_links":{"self":[{"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/posts\/2823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/comments?post=2823"}],"version-history":[{"count":32,"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/posts\/2823\/revisions"}],"predecessor-version":[{"id":2871,"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/posts\/2823\/revisions\/2871"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/media\/2869"}],"wp:attachment":[{"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/media?parent=2823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/categories?post=2823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/luminorecruit.com\/de\/wp-json\/wp\/v2\/tags?post=2823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}